Clinical Trial Update: Efficacy and Safety Study of Formoterol/Fluticasone and Salmeterol/Fluticasone in Patients With Moderate-to-severe COPD [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Formoterol/Fluticasone and Salmeterol/Fluticasone for moderate-to-severe chronic obstructive pulmonary disease was withdrawn from the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Formoterol/Fluticasone (formoterol/fluticasone)
• Salmeterol/Fluticasone (fluticasone propionate/salmeterol)

Snippet

Sponsor: Ache Laboratorios Farmaceuticos S.A. | Conditions: Chronic Obstructive Pulmonary Disease, COPD | Phase 3 | Status: WITHDRAWN